← Back to Arrigo, Lee, Guttman & Mouta-Bellum LLP
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18981938 | PHYSIOLOGICAL BIOMIMETIC CULTURE SYSTEM FOR HEART SLICES | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18858318 | BORON COMPOUNDS, RELATED LIPID PARTICLES, LIPOPLEXES, COMPOSITIONS, METHODS OF USE, AND METHODS OF MAKING | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | NOLAN, JASON MICHAEL | §102§112 | Non-Final OA | — | Pending | Oct 20, 2024 | |
| 18914680 | CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION | Cellectis | KIM, TAEYOON | 1631 | §103§112DP | Non-Final OA | — | Pending | Oct 14, 2024 |
| 18849851 | BIOSYNTHESIS | Plant Bioscience Limited | MOAZZAMI, NAGHMEH NINA | 1652 | §112Other | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18728027 | METHOD FOR DETECTING A TAU PROTEIN IN A SALIVA SAMPLE | Gtinvent Limited | MARCSISIN, ELLEN JEAN | 1677 | §103§112DP | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18744060 | Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing Tert | Kriptic Pharmaceuticals Limited | WEHBE, ANNE MARIE SABRINA | 1634 | §102§103DP | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18714448 | ARM-WORN ELECTROCARDIOGRAPHIC DEVICE AND METHOD FOR ELECTROCARDIOGRAPHIC SIGNAL MEASUREMENT | Demedar Spolka Z Ograniczona Odpowiedzialnoscia | SCHMITT, BENJAMIN ALLYN | 3796 | §103§112 | Non-Final OA | — | Pending | May 29, 2024 |
| 18701664 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | Artios Pharma Limited | NOLAN, JASON MICHAEL | 1623 | §112 | Non-Final OA | — | Pending | Apr 16, 2024 |
| 18613613 | Silk Packaging Applications | Cambridge Crops, Inc,.D.B.A./Mori | BLEDSOE, JOSHUA CALEB | 1762 | §103§112Other | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18598495 | BACTERIAL DELIVERY VEHICLE, PROCESS OF PRODUCTION AND USES THEREOF | Eligo Bioscience | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Final Rejection | — | Pending | Mar 07, 2024 |
| 18582939 | OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS | Institut Pasteur | BLUMEL, BENJAMIN P | 1671 | §102§103§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18424461 | PRODUCTION BACTERIAL CELLS AND USE THEREOF IN PRODUCTION METHODS | Eligo Bioscience | WANG, RUIXUE | 1672 | §103§112DP | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18291050 | IL-10 INDUCING POLYPEPTIDES AND USES THEREOF | Enterome S.A. | KATAKAM, SUDHAKAR | 1658 | §101§112 | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18579409 | IN VITRO GENERATION OF ORGANIZED 3D CELL STRUCTURES INCLUDING HEAD-TRUNK EMBRYO-LIKE STRUCTURES, USING EPIGENETIC REMODELING FACTORS-MICROFLUIDIC PLATFORM SUITABLE FOR THEIR GENERATION | INSERM | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | — | Pending | Jan 15, 2024 |
| 18571892 | METHODS FOR DIAGNOSING A CANCER- OR ANTIBIOTICS-INDUCED DYSBIOSIS AND THEIR USE FOR IMPROVING CANCER TREATMENT BY IMMUNOTHERAPY | INSERM | BERA, HENA RAKESHKUMAR | 1798 | §101§103§112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18530878 | METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY | Cellectis | NGUYEN, QUANG | 1631 | §102§103§112DP | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18556957 | NEW ANTI-MUC1 CARS AND GENE EDITED IMMUNE CELLS FOR SOLID TUMORS CANCER IMMUNOTHERAPY | Cellectis S.A. | WEN, SHARON X | 1641 | §103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18547242 | AN ARTIFICIAL PROTEIN-CAGE COMPRISING ENCAPSULATED THEREIN A GUEST CARGO | UNIWERSYTET JAGIELLONSKI | KIEFER, DALTON EDWARD | 1652 | §102§103§112DP | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18551043 | LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH CATHETER-BASED DELIVERY | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | KHANDKER, RAIHAN R | 3771 | §103 | Final Rejection | — | Pending | Sep 18, 2023 |
| 18549286 | LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST | Theravectys | KIM, YUNSOO | 1641 | §103§112DP | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18547471 | ANTIBODIES, FRAGMENTS OR DERIVATIVES SPECIFICALLY BINDING TO A PROTEIN ANTIGEN CAPABLE OF BINDING TO NUCLEIC ACIDS AND USES OF SAME | COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES | DRISCOLL, LORA E BARNHART | 3991 | §112 | Final Rejection | 25d overdue | Pending | Aug 22, 2023 |
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | UNIWERSYTET JAGIELLONSKI | SWIFT, CANDICE LEE | 1657 | §112 | Final Rejection | 4d overdue | Pending | Aug 21, 2023 |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | Universite Paris-Saclay | REGLAS, GEORGIANA C | 1651 | §102§103 | Final Rejection | 5d overdue | Pending | Jul 21, 2023 |
| 18259979 | DRUG ELUTING STENT | Sino Medical Sciences Technology Inc. | LYNCH, ROBERT A | 3771 | §102§112 | Non-Final OA | 71d overdue | Pending | Jun 29, 2023 |
| 18258271 | BIOMARKERS SIGNATURE(S) FOR THE PREVENTION AND EARLY DETECTION OF GASTRIC CANCER | Universite De Versailles Saint Quentin En Yvelines | BUCHANAN, BAILEY CHEYENNE | 1682 | §101§103§112 | Final Rejection | — | Pending | Jun 19, 2023 |
| 17997439 | POROUS BONE SUBSTITUTION MATERIAL | Etat Francais Represente Par La Direction Centrale Du Service De Sante Des Armées | BLANCO, JAVIER G | 3774 | §102§103§112 | Final Rejection | 4d overdue | Pending | Jun 09, 2023 |
| 18002229 | Method for determining potency of chimeric antigen receptor expressing immune cells | Cellectis S.A. | HOWARD, ZACHARY C | 1674 | §102§112 | Final Rejection | 27d | Pending | May 23, 2023 |
| 18253977 | USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION | Cellectis SA | SU-TOBON, QIWEN NMN | 1636 | §102§103 | Non-Final OA | 63d | Pending | May 23, 2023 |
| 18252438 | PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE AS ACTIVE INGREDIENT | Intract Pharma Limited | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | May 10, 2023 |
| 18250569 | NEW SPLICE VARIANT ISOFORM OF VEGF | Centre Scientifique De Monaco | MCKNIGHT, CIARA A | 1655 | §101 | Non-Final OA | — | Pending | Apr 26, 2023 |
| 18040945 | Method for separation and/or detection and/or in vitro quantification of infectious compounds in biological material | Apoh-Technologies | HELLMAN, KRISTINA M | 1654 | §102§112 | Non-Final OA | — | Pending | Feb 07, 2023 |
| 18005284 | T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS | Cellectis S.A. | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | 26d overdue | Pending | Jan 12, 2023 |
| 18005146 | SARS-COV-2 IMMUNOGENIC COMPOSITIONS, VACCINES, AND METHODS | Theravectys | CHEN, STACY BROWN | 1672 | §102§103§112DP | Non-Final OA | — | Pending | Jan 11, 2023 |
| 17997764 | BIOMIMETIC HEART TISSUE CULTURE SYSTEM | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | HENKEL, DANIELLE B | 1799 | §103§112 | Non-Final OA | — | Pending | Nov 02, 2022 |
| 17996733 | METHODS FOR TARGETED INSERTION OF EXOGENOUS SEQUENCES IN CELLULAR GENOMES | Cellectis S.A. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | §102§103 | Non-Final OA | — | Pending | Oct 20, 2022 |
| 17907324 | NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT | INSERM | OTTON, ALICIA L | 1699 | §102 | Final Rejection | — | Pending | Oct 03, 2022 |
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | KIM, TAEYOON | 1631 | §103§112Other | Final Rejection | 12d | Pending | Jul 12, 2022 |
| 17789749 | COMPOSITION COMPRISING HYALURONIC ACID AND A POLYOL AND/OR CARBOXYMETHYL CELLULOSE | Ibsa Pharma SAS | CHO, DAVID H | 1693 | §112 | Final Rejection | 8d overdue | Pending | Jun 28, 2022 |
| 17781652 | USE OF CELL FREE NUCLEOSOMES AS BIOMARKERS | Belgian Volition Srl | AEDER, SEAN E | 1642 | §101 | Final Rejection | 25d overdue | Pending | Jun 01, 2022 |
| 17780336 | METHOD OF LYOPHILIZATION OF A CRYOGENIZED CELLULAR COMPOSITION CONTAINING DISSOLVED GAS | Larena | MCKNIGHT, CIARA A | 1656 | §103 | Non-Final OA | — | Pending | May 26, 2022 |
| 17742173 | VITRO ISOLATION AND ENRICHMENT OF NUCLEIC ACIDS USING SITE-SPECIFIC NUCLEASES | Depixus | GRAY, JESSICA | 1682 | §102§103 | Final Rejection | 72d | Pending | May 11, 2022 |
| 17741686 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | JONES, DAMERON LEVEST | 1618 | §102§112Other | Final Rejection | — | Pending | May 11, 2022 |
| 17768002 | GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER | Sorbonne Universite | BURKHART, MICHAEL D | 1638 | §112 | Final Rejection | — | Pending | Apr 11, 2022 |
| 17761767 | A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS | Institut Pasteur Du Cambodge | BLUMEL, BENJAMIN P | 1671 | §101§103§112 | Non-Final OA | — | Pending | Mar 18, 2022 |
| 17641787 | ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | MEJIAS, SAMANTHA LEE | 1618 | §102§103§112Other | Final Rejection | 3d overdue | Pending | Mar 09, 2022 |
| 17634373 | METHOD FOR IN VITRO PRODUCTION OF HYALINE CARTILAGE TISSUE | Vanarix SA | MARTIN, PAUL C | 1653 | §103 | Final Rejection | — | Pending | Feb 10, 2022 |
| 17620819 | ANTHRACYCLINE DERIVATIVES | Almac Discovery Limited | HOPKINS, SAMANTHA LAKE | 1641 | §103§112Other | Final Rejection | — | Pending | Dec 20, 2021 |
| 17422737 | AAV-MEDIATED GENE THERAPY RESTORING THE OTOFERLIN GENE | INSERM | KIM, TAEYOON | 1631 | §102§103 | Final Rejection | 15d overdue | Pending | Jul 13, 2021 |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | UNIWERSYTET JAGIELLONSKI | SPANGLER, JOSEPH RANKIN | 1656 | §103§112Other | Final Rejection | — | Pending | Feb 16, 2021 |
| 16789572 | MODULAR HARNESS FOR PATIENTS WITH POST-NEUROLOGIC INJURY | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | MILLER, CHRISTOPHER E | 3785 | §103 | Non-Final OA | — | Pending | Feb 13, 2020 |
| 15713347 | WIDESPREAD GENE DELIVERY TO MOTOR NEURONS USING PERIPHERAL INJECTION OF AAV VECTORS | Centre National De La Recherche Scientifique | SINGH, ANOOP KUMAR | 1632 | §112 | Non-Final OA | — | Pending | Sep 22, 2017 |
